A malaria vaccine with genetically weakened parasites does not cause malaria in healthy volunteers.The vaccine was safely given to 19 healthy volunteers. With this good news, the first phase of the research into this vaccine was completed. The next burning question is: how well does the vaccine protect against malaria?
Read more about the first clinical trial here.
Robert Sauerwein in the media, watch the video here (only in Dutch).